Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs Diclofenac in Ankylosing Spondylitis
NCT00648141Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib oral solution in ankylosing spondylitis (AS), sponsored by Pfizer. Started Jan 2003; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00648141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00648141.